Gossamer Bio
Erin Elman has extensive experience in clinical operations, with a focus on vendor management and rare diseases. From April 2019 to May 2023, Erin served as Executive Director of Clinical Operations at Gossamer Bio, having previously held roles as Senior Director and Associate Director in the same department. After leaving Gossamer Bio, Erin worked as Senior Director at Alladapt Immunotherapeutics, Inc. From July 2017 to March 2018, Erin was a Clinical Trial Manager (Consultant) at Receptos, a subsidiary of Celgene, and previously worked as a Clinical Study Manager (Consultant) at Daiichi Sankyo, Inc. Erin holds an MBA from San Francisco State University and a B.A. in Psychology from the University of California, Berkeley.
This person is not in any teams
This person is not in any offices
Gossamer Bio
1 followers
Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.